# Are y’all ordering in bulk to Texas before 3/31?

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/are-yall-ordering-in-bulk-to-texas-before-3-31/
> **Published:** 2026-03-14T10:02:13-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:58:51-04:00
> **Clinical Summary:** When the federal scheduling timeline gets tighter than your supply chain logistics, suddenly everyone’s doing advanced inventory planning. Via r/trees Further Reading Cannabis Policy WirePolicy Watch: 16 Regulatory Updates — March 13, 2026 Research DigestAM Policy Update: March 11, 2026 Evidence WatchCannabinoid Clinical Trials: CBD Cortical Excitability Study

---

When the [federal scheduling](https://cedclinic.com/investigator-initiated-cannabis-research-barriers/) timeline gets tighter than your supply chain logistics, suddenly everyone’s doing advanced inventory planning.

Via [r/trees](https://reddit.com/r/trees/comments/1rsqe8o/are_yall_ordering_in_bulk_to_texas_before_331/)

Further Reading
Cannabis Policy Wire[Policy Watch: 16 Regulatory Updates — March 13, 2026](https://cedclinic.com/cannabis-medicine-regulations-2026-march-13-updates/)
Research Digest[AM Policy Update: March 11, 2026](https://cedclinic.com/dea-rescheduling-marijuana-march-11-2026/)
Evidence Watch[Cannabinoid Clinical Trials: CBD Cortical Excitability Study](https://cedclinic.com/cannabidiol-lacks-intrinsic-anti-epileptic-properties-trial/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).